SI-BONE, Inc. Common Stock (SIBN) is a publicly traded Healthcare sector company. As of July 21, 2026, SIBN trades at $17.08 with a market cap of $770.79M and a P/E ratio of -22.96. SIBN moved -0.23% today. Year to date, SIBN is -13.10%; over the trailing twelve months it is +3.01%. Its 52-week range spans $11.48 to $21.89. Analyst consensus is strong buy with an average price target of $23.25. Rallies surfaces SIBN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for SIBN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $17.08 |
| Market Cap | $770.79M |
| P/E Ratio | -22.96 |
| EPS | $-0.75 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.89 |
| 52-Week Low | $11.48 |
| Volume | 116.35K |
| Avg Volume | 0 |
| Revenue (TTM) | $167.18M |
| Net Income | $-30.91M |
| Gross Margin | 79.03% |
5 analysts cover SIBN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $23.25.